Anuh Pharma reclassifies nine shareholders to public category
Anuh Pharma Limited approved the reclassification of nine shareholders from the promoter group to the public category, holding 0.95% of the total paid-up share capital. The Board confirmed compliance with Regulation 31A of SEBI LODR Regulations, noting the individuals are not involved in management or control. The company will seek stock exchange approvals to finalize the reclassification.
*this image is generated using AI for illustrative purposes only.
Anuh Pharma Limited has approved the reclassification of nine shareholders from the promoter group to the public category. The decision was made during the Board of Directors meeting held on May 20, 2026. The company had initially received requests from these shareholders on May 19, 2026, seeking the change in status under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The shareholders requesting the change collectively hold 9,49,988 equity shares, representing 0.95% of the company's total paid-up share capital. The applicants include individuals such as Kinjal Siddharth Jhaveri, who holds the largest portion among the applicants at 0.81%, and others like Nina Vijay Shah and Hemant Babubhai Choksi.
Details of Shareholders Seeking Reclassification
The following table outlines the shareholders approved for reclassification along with their respective holdings:
| Sr No. | Name | Number of Equity shares held | % of shareholding |
|---|---|---|---|
| 1. | Madhurika Narendra Shah | 12,000 | 0.01 |
| 2. | Hemant Babubhai Choksi | 24,000 | 0.02 |
| 3. | Mukesh Kantilal Shah | 14,400 | 0.01 |
| 4. | Aruna Navnit Shah | 5,040 | 0.01 |
| 5. | Vikram Kirtilal Shah | 200 | 0.00 |
| 6. | Kiran Piyush Shah | 15,388 | 0.02 |
| 7. | Kinjal Siddharth Jhaveri | 8,16,160 | 0.81 |
| 8. | Nina Vijay Shah | 60,000 | 0.06 |
| 9. | Neela Pradeep Shah | 2,800 | 0.003 |
| TOTAL | 9,49,988 | 0.95 |
Regulatory Compliance and Undertakings
The Board confirmed that these individuals are immediate relatives of promoters and are no longer involved in the day-to-day affairs or management of anuh pharma . They stated that they do not exercise control over the company's affairs or possess special rights through formal or informal arrangements.
The outgoing promoters confirmed they do not hold more than 10% of the total voting rights, are not represented on the Board of Directors, and do not act as key managerial personnel. They also verified that they are not wilful defaulters or fugitive economic offenders, and there is no pending regulatory action against them.
Next Steps
The company will now take appropriate steps to secure the necessary approvals from stock exchanges. Once these approvals are received, the outgoing promoters will be officially reclassified as public shareholders.
Historical Stock Returns for Anuh Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.77% | -4.30% | -6.41% | -5.01% | -28.48% | -32.17% |
How might the reduction in promoter holding percentage impact investor confidence and Anuh Pharma's stock performance once the reclassification is officially approved by the stock exchanges?
Could the reclassification of these shareholders signal a broader dilution of promoter control at Anuh Pharma, and are there indications of further reclassification requests from remaining promoter group members?
How will Kinjal Siddharth Jhaveri's transition to public shareholder status, holding 0.81% of shares, potentially influence trading volumes or attract institutional interest in Anuh Pharma?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
